John Overdeck’s SpringWorks Therapeutics SWTX Stock Holding History
Bought
Maintained
Sold
Other funds holding SWTX
DTC
BCM
MC
John Overdeck's SWTX Position: Q4 2024 in Review
John Overdeck sold out of SpringWorks Therapeutics (SWTX) in Q4 2024, closing a stake of 153,365 shares — an estimated $4.91M sold.
John Overdeck first reported a position in SWTX in Q4 2020 and held it in 15 quarters. The position peaked at $9.28M in Q3 2021. 216 funds tracked by Wall St. Rank hold SWTX as of Q4 2024.
- John Overdeck reported no remaining SpringWorks Therapeutics position as of Q4 2024 after selling out during the quarter.
- John Overdeck sold 153,365 SpringWorks Therapeutics shares in Q4 2024, an estimated $4.91M.
- John Overdeck first reported a position in SpringWorks Therapeutics in Q4 2020 and held it in 15 quarters.
- John Overdeck's SpringWorks Therapeutics position peaked at $9.28M in Q3 2021.
- 216 funds tracked by Wall St. Rank held SpringWorks Therapeutics as of Q4 2024.
Based on Two Sigma Investments's 13F filing for Q4 2024, filed 14 Feb 2025.